• Located in the Eisa building, the centre will primarily focus on Sharjah residents
  • The centre was inaugurated by Mr Prasanth Manghat, CEO NMC Healthcare and Mr Michael Davis, COO NMC Healthcare

NMC healthcare has announced the opening of a new multi-specialty Medical Centre in Al Rolla, Sharjah. The new 22,000 sq. ft. NMC Medical Centre will provide specialised medical services to the residents of Sharjah. The state-of-the-art facility has 23 doctors practicing 18 different specialities including Obstetrics and Gynaecology, Paediatrics, Cardiology, Neurology, Endocrinology, Ophthalmology, Orthopaedic, Dermatology, Psychiatry and Child Guidance.

The brief inauguration ceremony was presided over by Mr Prasanth Manghat, CEO NMC Healthcare and Mr Michael Davis, COO NMC Health care. They were joined by a host of senior officials and local community members.

NMC Healthcare is the largest private healthcare company in the UAE. NMC, which today provides 145 facilities, is the first company from Abu Dhabi to list on the London Stock Exchange.

Commenting on the new location Prasanth Manghat, CEO and Executive Director NMC Health Plc said: Life is fragile and precious; NMC is committed to preserve and nurture life while leading the healthcare industry and providing the best in class services to the residents of the UAE and the GCC region at large. We are also expanding our network into Ajman to fill the service gaps in community healthcare. This is in line with the UAE’s healthcare goals, where we endeavour to invest in collaborations, introducing technologies and medical programmes to provide constant – and consistent – support to our communities.

NMC Medical Centre, Rolla is committed to providing consistently superior quality health care services, focused on those living within a convenient distance of the new facility. Addressing the day to day healthcare needs of patients, the centre offers highly advanced treatments, with clients benefitting from detailed evaluations and ongoing assessments.

-Ends-

About NMC Health
NMC Health plc is the leading private sector healthcare operator based in the United Arab Emirates. Having started its operations in the country in 1975, the group has expanded across the GCC, Europe and South America and now lays claim to 145 healthcare facilities across 13 countries. NMC Healthcare employ more than 2,000 doctors and 18,000 administrative and support staff who cater to more than 8.5 million patients per year.

The group is also a leading UAE distributor of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Trading, a subsidiary of NMC Health plc, is one of the largest distributors in the UAE with distribution rights for some of the most iconic brands from around the world, including 3M, Medtronic, Welch Allyn, Meyra, Sorg, Patron, Abbott Diabetes Care, Nestle, Unilever, Nivea, Pfizer, Siemens, Samsung, Sanofi, Kiwi, Brylcreem, and Henkel, among others. NMC Trading sells products and services to over 10,000 businesses across the UAE.

NMC Health plc reported revenues of US$1603.4 m in 2017. In April 2012 NMC Health plc became the first healthcare company from the GCC to list on the London Stock Exchange (LSE). NMC Health plc is a constituent of the coveted FTSE 100 Index of the blue-chip companies at the LSE.

To   find   out   more   visit: https://nmc.ae/ 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.